Investigation, treatment, and outcome in 274 TB cases in New Zealand children, 1992–2001
| Number* | %† | |
|---|---|---|
| *The denominator is 274 unless otherwise stated; †rounding and allowance for multiple ethnicity results in some percentages not equalling 100; ‡defined as resistance to two or more drugs including isoniazid and rifampicin; §these included neurological deficits (5), bronchiectasis (3), limb abnormalities (2), cardiac complications (1), and pelvic scarring likely to result in infertility (1). | ||
| Mantoux test | ||
| Positive | 234/264 | 89 |
| Median (range) measurement (mm) | 18 (6–63) | |
| Chest radiograph findings in | ||
| pulmonary TB (n = 256) | ||
| Hilar or mediastinal adenopathy | 186 | 73 |
| Consolidation or atelectasis | 150 | 59 |
| Pleural effusion | 38 | 15 |
| Culture positive | 102 | 38 |
| Treatment | ||
| 3 or more agents | 253 | 92 |
| 6 months or more duration | 240 | 97 |
| Directly observed therapy (any) | 109 | 40 |
| Drug resistant strains (any) | 7/102 | 7 |
| Multi-drug resistant strains‡ | 1/102 | 1 |
| Outcome | ||
| Death | 2 | 0.7 |
| Long term sequelae§ | 12 | 4 |
| Recurrence of disease | 6 | 2 |